Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01429701Phase 3Completed
A Phase 3 trial of prednisolone + neomycin in eczematous dermatitis, sponsored by EMS. Started May 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01429701.